Jason Ferreira

849 total citations
39 papers, 598 citations indexed

About

Jason Ferreira is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine and Surgery. According to data from OpenAlex, Jason Ferreira has authored 39 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 11 papers in Critical Care and Intensive Care Medicine and 10 papers in Surgery. Recurrent topics in Jason Ferreira's work include Sepsis Diagnosis and Treatment (10 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Jason Ferreira is often cited by papers focused on Sepsis Diagnosis and Treatment (10 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Jason Ferreira collaborates with scholars based in United States and United Kingdom. Jason Ferreira's co-authors include Donald W. Johnson, Christopher Jankowski, Yvette S. McCarter, Nilmarie Guzman, Brittany D. Bissell, Michael Erdman, Melanie Smith, Faheem W. Guirgis, Carmen Smotherman and Brittany Johnson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jason Ferreira

33 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Ferreira United States 16 206 124 119 110 103 39 598
Vasileios Karamouzos Greece 16 285 1.4× 44 0.4× 87 0.7× 108 1.0× 114 1.1× 50 849
Christian Eckmann Germany 11 242 1.2× 82 0.7× 119 1.0× 107 1.0× 106 1.0× 23 925
Gourang Patel United States 15 386 1.9× 76 0.6× 146 1.2× 157 1.4× 120 1.2× 36 803
Irene Aragão Portugal 13 183 0.9× 49 0.4× 59 0.5× 94 0.9× 64 0.6× 38 491
Rodrigo Vazquez Guillamet United States 15 244 1.2× 48 0.4× 115 1.0× 100 0.9× 175 1.7× 62 838
Becky Bates United States 10 478 2.3× 103 0.8× 161 1.4× 210 1.9× 81 0.8× 16 664
Jeffrey M. Tessier United States 10 169 0.8× 73 0.6× 115 1.0× 59 0.5× 95 0.9× 21 600
Rébecca Hamidfar-Roy France 13 335 1.6× 51 0.4× 234 2.0× 148 1.3× 193 1.9× 20 834
Melanie Smith United States 10 199 1.0× 62 0.5× 201 1.7× 94 0.9× 42 0.4× 33 543
Marc Garnier France 11 242 1.2× 55 0.4× 135 1.1× 60 0.5× 127 1.2× 53 732

Countries citing papers authored by Jason Ferreira

Since Specialization
Citations

This map shows the geographic impact of Jason Ferreira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Ferreira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Ferreira more than expected).

Fields of papers citing papers by Jason Ferreira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Ferreira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Ferreira. The network helps show where Jason Ferreira may publish in the future.

Co-authorship network of co-authors of Jason Ferreira

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Ferreira. A scholar is included among the top collaborators of Jason Ferreira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Ferreira. Jason Ferreira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Logan, et al.. (2025). Safety and efficacy of thrombolytic interventions in the treatment of intermediate and high-risk pulmonary embolism. Blood Coagulation & Fibrinolysis. 36(6). 253–260.
2.
Guirgis, Faheem W., Lauren Page Black, Morgan Henson, et al.. (2024). The Lipid Intensive Drug Therapy for Sepsis Phase II Pilot Clinical Trial*. Critical Care Medicine. 52(8). 1183–1193. 5 indexed citations
3.
Xue, Wei, et al.. (2022). Evaluation of Glycemic Control in Critically ill Patients with Bacteremia: A Retrospective, Single-Center Cohort Study. Journal of Investigative Medicine. 70(6). 1387–1391.
4.
Coyne, Ashlan J. Kunz, et al.. (2021). 1114. Effectiveness and Safety of Beta-lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection. Open Forum Infectious Diseases. 8(Supplement_1). S650–S650. 1 indexed citations
5.
Guirgis, Faheem W., Lauren Page Black, Elizabeth DeVos, et al.. (2020). Lipid intensive drug therapy for sepsis pilot: A Bayesian phase I clinical trial. Journal of the American College of Emergency Physicians Open. 1(6). 1332–1340. 8 indexed citations
6.
Johnson, Donald W., et al.. (2020). Comparison of weight-based dosing versus fixed dosing of 23.4% hypertonic saline for intracranial pressure reduction in patients with severe traumatic brain injury. Journal of Emergencies Trauma and Shock. 13(4). 252–252. 4 indexed citations
8.
Ferreira, Jason, et al.. (2018). Thromboelastography in the management of snakebite-induced coagulopathy. Blood Coagulation & Fibrinolysis. 29(7). 656–660. 15 indexed citations
9.
Ferreira, Jason. (2017). The Theory is Out There: The Use of ALPHA-2 Agonists in Treatment of Septic Shock. Shock. 49(4). 358–363. 15 indexed citations
10.
Guirgis, Faheem W., et al.. (2017). Managing sepsis: Electronic recognition, rapid response teams, and standardized care save lives. Journal of Critical Care. 40. 296–302. 53 indexed citations
11.
Jankowski, Christopher, et al.. (2017). Evaluation of sedation-related medication errors in patients on contact isolation in the intensive care unit. Journal of Hospital Infection. 98(2). 175–180. 6 indexed citations
13.
Ferreira, Jason, et al.. (2016). The impact of push-dose phenylephrine use on subsequent preload expansion in the ED setting. The American Journal of Emergency Medicine. 34(12). 2419–2422. 20 indexed citations
14.
Ferreira, Jason, et al.. (2016). Idarucizumab for Reversal of Dabigatran-Associated Bleeding: Misnomer or Miracle?. Journal of Emergency Medicine. 52(3). 341–347. 2 indexed citations
15.
Ferreira, Jason, et al.. (2016). Impact of an antimicrobial stewardship initiative to evaluate β-lactam allergy in patients ordered aztreonam. American Journal of Health-System Pharmacy. 73(5_Supplement_1). S8–S13. 21 indexed citations
16.
Johnson, Donald W., et al.. (2016). Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis. Journal of Critical Care. 37. 206–210. 25 indexed citations
17.
Ferreira, Jason & Donald W. Johnson. (2015). The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients. Renal Failure. 37(7). 1232–1236. 37 indexed citations
18.
Ferreira, Jason, et al.. (2015). The role of inhaled prostacyclin in treating acute respiratory distress syndrome. Therapeutic Advances in Respiratory Disease. 9(6). 302–312. 35 indexed citations
19.
Ferreira, Jason, et al.. (2015). Pneumonia and disseminated bacteremia with Pasteurella multocida in the immune competent host: A case report and a review of the literature. SHILAP Revista de lepidopterología. 15. 54–56. 19 indexed citations
20.
Ferreira, Jason, et al.. (2013). The Clinical Use of Prothrombin Complex Concentrate. Journal of Emergency Medicine. 44(6). 1201–1210. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026